Evidence map›Paper›PMID 42454053›Full record

ArticleFrontiers in immunology2026

A rare case report: The impact of

Lurun Wang, Wenbing Lai, Yuze Liu, Jinwen Huang, Haixia Jing, Xianhui Wang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lurun WangDepartment of Dermatology, Taihe Hospital, Biomedical Research Institute, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.
Wenbing LaiDepartment of Dermatology, Taihe Hospital, Biomedical Research Institute, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.
Yuze LiuDepartment of Dermatology, Taihe Hospital, Biomedical Research Institute, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.
Jinwen HuangDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Haixia JingDepartment of Dermatology, Taihe Hospital, Biomedical Research Institute, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.
Xianhui WangDepartment of Dermatology, Taihe Hospital, Biomedical Research Institute, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals living with HIV/AIDS may be more susceptible to various opportunistic infections due to an immunocompromised status, which can result in diverse clinical manifestations. Among potential pathogens,

Indexed as

Acquired Immunodeficiency SyndromeAIDS-Related Opportunistic InfectionsHIV InfectionsMycobacteriumMycobacterium Infections, NontuberculousAntitubercular AgentsBacilloscopyClarithromycinFemaleHumansMiddle AgedTreatment OutcomeAntitubercular AgentsClarithromycincase reportHIV/AIDSimmunocompromised individualsmolecular diagnosticsMycobacterium colombienseopportunistic infectionsskin involvement

Identifiers

PMID42454053
PMCPMC13364589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.